Benefits of the povidone-iodine: simultaneously decrease risk of infection and tumor seeding after percutaneous...

Area of Science:

• Gastroenterology
• Oncology
• Infectious Diseases

Background:

• Percutaneous endoscopic gastrostomy (PEG) is crucial for enteral feeding in oropharyngeal/esophageal cancer patients.
• PEG insertion carries risks, including peristomal infection from microbial transport and tumor seeding along the PEG tract.
• Oropharyngeal/esophageal cancer cells pose a risk for adherence to PEG tubes.

Purpose of the Study:

• To evaluate the efficacy of povidone-iodine pretreatment in reducing PEG-related complications.
• To test the hypothesis that povidone-iodine's microbicidal and tumoricidal properties mitigate infection and tumor seeding.
• To assess the impact of povidone-iodine on peristomal infection and tumor seeding in cancer patients undergoing PEG insertion.

Main Methods:

• PEG tubes were pretreated by brushing povidone-iodine onto their outer surfaces.
• The study involved patients with oropharyngeal/esophageal cancer requiring PEG insertion.
• The primary outcome was the incidence of peristomal infection and tumor seeding.

Main Results:

• Povidone-iodine pretreatment demonstrated potential in decreasing peristomal infection.
• The study indicated a possible reduction in tumor seeding along the PEG tract.
• Further clinical data is needed to confirm the protective effects.

Conclusions:

• Povidone-iodine pretreatment of PEG tubes is a promising strategy to reduce complications in cancer patients.
• This intervention may lower the risk of infection and tumor seeding associated with PEG insertion.
• Further research is warranted to validate these findings in larger cohorts.